• Home
  • DTx
  • Use of WeChat-based patient-doctor interaction improves patient experience of Helicobacter pylori treatment: a randomized controlled trial

IntroductionHelicobacter pylori (H. pylori) eradication therapy often involves complex medication regimens and may be accompanied by adverse events, which can negatively affect treatment outcomes and experience. Effective patient-doctor communication may help address these challenges. This study primarily aimed to evaluate whether a WeChat-based patient-doctor interaction (WPDI) system could improve H. pylori treatment outcomes while simultaneously enhancing patient experience.MethodsIn this prospective, open-label randomized controlled trial, treatment-naïve H. pylori-infected patients were randomly assigned (1:1) to either a WPDI group or a control group. All participants received routine patient education and a 14-day vonoprazan-containing quadruple therapy. In addition to routine education, patients in the WPDI group were invited to participate in a physician-moderated WeChat group that allowed real-time communication and consultation during treatment. Patient experience, compliance, and adverse events were assessed through a standardized telephone interview after completion of therapy, and H. pylori eradication was confirmed by a 13C-urea breath test six weeks after treatment. This study was registered at clinicaltrials.gov. (No. NCT04850209).ResultsIn total, 438 patients were enrolled for randomization. The WPDI group achieved eradication rates of 90.4% (198/219), 93.4% (198/212), and 94.2% (194/206), as evaluated by intention-to-treat, modified intention-to-treat, and per-protocol analysis, respectively. The eradication rates were comparable to those in the control group (89.5% [196/219], 93.3% [196/210], and 94.6% [192/203]. The assessment results of patient experience showed that more patients voted that the treatment was satisfactory or very satisfactory in the WPDI group (90.3% vs. 74.9%; P < 0.001), whereas more participants tended to feel worried (16.0% vs. 26.1%; P = 0.012) and perturbed (11.7% vs. 22.7%; P = 0.003) during the treatment period in the control group. The two groups exhibited similar levels of compliance and adverse events.ConclusionsThe WeChat-based patient-doctor interaction improved patient experience of H. pylori eradication therapy significantly while the treatment outcomes were not promoted significantly.
Clinical Trial RegistrationClinicalTrials.gov ID: NCT04850209.

Subscribe for Updates

Copyright 2025 dijee Intelligence Ltd.   dijee Intelligence Ltd. is a private limited company registered in England and Wales at Media House, Sopers Road, Cuffley, Hertfordshire, EN6 4RY, UK registration number 16808844